Mylan CEO Heather Bresch’s father sponsored a bill that made it easier for generic drugs to be substituted back in 1986. This helped Mylan become the largest generic manufacturer.
Category: Mylan Laboratories
Is This The Best Biotech Play for 2017?
Last year, a political spotlight on drug pricing policies threatened the entire industry. Scandals at Mylan and Valeant Therapeutics did damage to the entire sector, sending the share prices of many biotech companies down.
EpiPen competitor to launch in February
A major competitor to EpiPen, the lifesaving allergy injection that has become the latest flashpoint in the debate over high drug prices, will launch on Valentine’s Day at a list price of $360 for a two-pack, the company KalA o announced on Thursday. For years, pharmaceutical company Mylan hiked the price on EpiPen — to $609 for a two-pack, enjoying a near monopoly on the growing allergy injection market.
3 Troubled Companies and How to Play Them in the New Year
The share prices of Mylan, Sears and Endo International fell dramatically in 2016, and the companies face significant challenges ahead. On a day of light economic news, the three major indices fell slightly Friday.